BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34609950)

  • 21. Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
    Percik R; Shlomai G; Tirosh A; Tirosh A; Leibowitz-Amit R; Eshet Y; Greenberg G; Merlinsky A; Barhod E; Steinberg-Silman Y; Sella T
    Autoimmun Rev; 2020 Feb; 19(2):102454. PubMed ID: 31838158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study.
    Cui K; Wang Z; Zhang Q; Zhang X
    Ann Transl Med; 2022 Mar; 10(5):251. PubMed ID: 35402601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma.
    Hata K; Sakaguchi C; Tsuchiya M; Nagasaka Y
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report.
    Simeni Njonnou SR; Aspeslagh S; Ntsama Essomba MJ; Racu ML; Kemta Lekpa F; Vandergheynst F
    J Med Case Rep; 2022 Dec; 16(1):456. PubMed ID: 36482425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors.
    Heck A; Winge-Main AK
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34045201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare clinical problem - isolated ACTH deficiency associated with chronic alcohol abuse.
    Skowrońska-Jóźwiak E; Orzechowski S; Piętak W; Lewiński A
    Endokrynol Pol; 2022; 73(4):778-783. PubMed ID: 35971928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.
    Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T
    Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.
    Ishiguro A; Ogata D; Ohashi K; Hiki K; Yamakawa K; Jinnai S; Tsutsui K; Takahashi A; Namikawa K; Yamazaki N
    Medicine (Baltimore); 2022 Sep; 101(35):e30398. PubMed ID: 36107581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
    Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
    Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.
    Brown LJ; Weppler A; Bhave P; Allayous C; Patrinely JR; Ott P; Sandhu S; Haydon A; Lebbe C; Johnson DB; Long GV; Menzies AA; Carlino MS
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
    Kurokawa K; Mitsuishi Y; Shimada N; Ito N; Ogiwara M; Miura K; Asao T; Ko R; Shukuya T; Shibayama R; Goto H; Takahashi K
    Thorac Cancer; 2023 Feb; 14(5):442-449. PubMed ID: 36523162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
    Pires da Silva I; Ahmed T; Reijers ILM; Weppler AM; Betof Warner A; Patrinely JR; Serra-Bellver P; Allayous C; Mangana J; Nguyen K; Zimmer L; Trojaniello C; Stout D; Lyle M; Klein O; Gerard CL; Michielin O; Haydon A; Ascierto PA; Carlino MS; Lebbe C; Lorigan P; Johnson DB; Sandhu S; Lo SN; Blank CU; Menzies AM; Long GV
    Lancet Oncol; 2021 Jun; 22(6):836-847. PubMed ID: 33989557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rare Cause of Adrenal Insufficiency - Isolated ACTH Deficiency Due to TBX19 Mutation: Long-Term Follow-Up of Two Cases and Review of the Literature.
    Kardelen Al AD; Poyrazoğlu Ş; Aslanger A; Yeşil G; Ceylaner S; Baş F; Darendeliler F
    Horm Res Paediatr; 2019; 92(6):395-403. PubMed ID: 32344415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Scott ES; Long GV; Guminski A; Clifton-Bligh RJ; Menzies AM; Tsang VH
    Eur J Endocrinol; 2018 Feb; 178(2):173-180. PubMed ID: 29187509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A middle aged woman with isolated ACTH deficiency associated with transient growth hormone deficiency.
    Hernán Martínez J; Mangual Garcia MM; Gutiérrez Acevedo M; Sánchez Cruz A; Laboy I; Rivera C; Mansilla P; Palermo Garofalo C; Lourdes Miranda M; Torres Rafael O
    Bol Asoc Med P R; 2016; 108(1):5-8. PubMed ID: 29192748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.
    Alrabadi NN; Abushukair HM; Ababneh OE; Syaj SS; Al-Horani SS; Qarqash AA; Darabseh OA; Al-Sous MM; Al-Aomar SR; Ahmed YB; Haddad R; Al Qarqaz FA
    Clin Transl Oncol; 2021 Sep; 23(9):1885-1904. PubMed ID: 33877531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis.
    Xu C; Chen YP; Du XJ; Liu JQ; Huang CL; Chen L; Zhou GQ; Li WF; Mao YP; Hsu C; Liu Q; Lin AH; Tang LL; Sun Y; Ma J
    BMJ; 2018 Nov; 363():k4226. PubMed ID: 30409774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
    Pierrard J; Petit B; Lejeune S; Seront E
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-specific variations in morphological patterns of injury in immune check-point inhibitor-associated colitis.
    Isidro RA; Ruan AB; Gannarapu S; Raj D; Rahma O; Grover S; Srivastava A
    Histopathology; 2021 Mar; 78(4):532-541. PubMed ID: 32931028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.